Omega Healthcare to post Q1 results April 28 after the close
Omega Healthcare Investors, Inc. (NYSE: OHI) announced that it will release its first-quarter 2026 earnings results on Tuesday, April 28, 2026, after market close. A conference call to review these results and current developments is scheduled for Wednesday, April 29, 2026, at 10 a.m. Eastern Time. Investors can access the call via webcast or telephone and review the earnings release on Omega's website.
Omega Announces First Quarter Earnings Release Date and Conference Call
Omega Healthcare Investors, Inc. (NYSE:OHI) has announced it will release its first-quarter 2026 earnings results on April 28, 2026, after market close. A conference call to discuss these results and current developments is scheduled for April 29, 2026, at 10 a.m. Eastern Time. Interested parties can access the call via the company's website, webcast, or by telephone.
OHI Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of Omega Healthcare Investors Inc (OHI), detailing its revenue breakdown, profitability margins, and a comparison with competitors. OHI boasts a gross margin of 98.63%, an operating margin of 63.19%, and a net margin of 53.87%, with a Return on Equity of 11.77%. The company, with a market capitalization of $13.30B, is benchmarked against industry leaders HST and LAMR, highlighting its strong efficiency metrics.
Aberdeen Group plc Boosts Holdings in Omega Healthcare Investors, Inc. $OHI
Aberdeen Group plc increased its stake in Omega Healthcare Investors (NYSE:OHI) by 7.4% in the fourth quarter of its latest filing, bringing its total ownership to 1,305,221 shares valued at approximately $57.9 million. Other major institutional investors like Vanguard and State Street also hold significant positions, with overall institutional ownership at 65.25%. Analysts currently rate OHI as a "Moderate Buy" with a consensus target price of $48.00, despite the company's high dividend payout ratio of 138.86%.
Omega Healthcare (NYSE: OHI) CAO logs ESPP award, tax shares and OP Unit conversions
Neal Ballew, Chief Accounting Officer of Omega Healthcare Investors (NYSE: OHI), reported acquiring 168 shares through the Employee Stock Purchase Plan and returning 8 shares for tax withholding. He also converted 20,483 Profits Interest Units into OP Units, and then into common stock. Following these transactions, Ballew directly holds 4,508 common shares and 148,322 OP Units.
Omega Healthcare (NYSE: OHI) CFO boosts stake through OP unit vesting
Omega Healthcare Investors' CFO, Robert O. Stephenson, increased his stake by exercising performance-based equity awards. He converted 79,298 Profits Interest Units into OP Units, which are exchangeable for cash or Omega common shares, at a $0.0000 exercise price. These units vested based on the company's Absolute and Relative Total Shareholder Return for the 2023–2025 performance period.
Omega Healthcare (NYSE: OHI) legal chief exercises 40,966 units
Gail D. Makode, the chief legal officer of Omega Healthcare Investors (NYSE: OHI), exercised 40,966 Profits Interest Units, converting them into OP Units on March 31, 2026. These units vested based on the company's Absolute and Relative Total Shareholder Return for the 2023–2025 performance period and required continued employment. After these transactions, Makode directly holds 101,201 Profits Interest Units and 224,508 OP Units.
[Form 4] OMEGA HEALTHCARE INVESTORS INC Insider Trading Activity
Omega Healthcare Investors President Matthew Paul Gourmand reported insider trading activity involving the vesting and conversion of Profits Interest Units (PIUs) into OP Units and then into common stock. The transactions, which occurred on March 31, 2026, involved two tranches of PIUs vesting into OP Units and subsequently converting into common shares at a $0.00 exercise price. These conversions were compensation-related and based on total shareholder return performance for the 2023-2025 period, resulting in Gourmand holding 211,876 shares of common stock directly after the transactions.
Omega Healthcare (OHI) CEO exercises performance units into additional stock
Omega Healthcare Investors CEO C. Taylor Pickett exercised performance-based equity awards, converting Profits Interest Units into OP Units and then into common stock at a $0.00 exercise price. This transaction, occurring on March 31, 2026, increased his direct holdings to 1,225,003 common shares. The vesting of these awards was based on Absolute and Relative Total Shareholder Return for the 2023–2025 period, subject to continued employment.
OHI Should I Buy
The article provides an analysis recommending Omega Healthcare Investors Inc (OHI) as a "good buy" for long-term beginner investors, citing its oversold status, strong RSI signal, increased hedge fund positions, and robust Q4 2025 financial growth. Despite some analyst caution regarding state budgetary concerns, the stock's long-term fundamentals in the senior housing and healthcare REIT sector are seen as strong. Analysts are mixed but leaning cautiously optimistic, with some raising price targets.
14 Most Profitable Real Estate Stocks Right Now
This article discusses Omega Healthcare Investors, Inc. (NYSE: OHI) as one of the most profitable real estate stocks. It highlights recent price target increases from Wells Fargo, Truist Securities, and Scotiabank, reflecting a positive outlook on the company's fundamentals and the broader Senior Housing sector within REITs. Omega Healthcare Investors operates as a REIT, focusing on financing and providing capital to the long-term healthcare industry, particularly skilled nursing and assisted living facilities.
Why the Street Isn’t Bullish on Omega Healthcare Investors, Inc. (OHI) – Yet
Omega Healthcare Investors, Inc. (OHI) has received recent price target adjustments from Wells Fargo, Truist Securities, and Scotiabank, with firms maintaining "Equal Weight" or "Hold" ratings. While OHI, a REIT focused on long-term healthcare, shows solid fundamentals in some areas, analysts express caution due to competition and a preference for other investment opportunities, particularly in AI stocks. Despite being recognized as a profitable real estate stock, the street isn't overly bullish, suggesting higher return potential elsewhere.
Vanguard subsidiaries to report OHI ownership separately (OHI)
The Vanguard Group has filed an amended Schedule 13G/A for Omega Healthcare Investors (OHI), reporting zero beneficial ownership following an internal realignment on January 12, 2026. This realignment means that certain Vanguard subsidiaries and business divisions will now report their beneficial ownership separately. The filing clarifies that Vanguard itself no longer holds beneficial ownership of Omega Healthcare Investors securities, but does not list the specific subsidiaries or their individual holdings.
Wealth Enhancement Advisory Services LLC Purchases 154,678 Shares of Omega Healthcare Investors, Inc. $OHI
Wealth Enhancement Advisory Services LLC significantly increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 171.3% in the fourth quarter, acquiring an additional 154,678 shares. The firm now holds 244,958 shares, valued at approximately $10.88 million. Omega Healthcare Investors, a real estate investment trust specializing in healthcare facilities, maintains a "Moderate Buy" consensus rating among analysts with an average target price of $48.00.
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $47
Wells Fargo analyst John Kilichowski has reiterated a "Hold" rating for Omega Healthcare Investors Inc (OHI.US) and increased the target price from $45 to $47. According to TipRanks data, Kilichowski has a 53.2% success rate and a 5.8% average return over the past year. TipRanks provides independent analysis of financial analysts' recommendations, including success rates and average returns, for informational purposes only.
Omega Healthcare Investors (NYSE:OHI) Given New $47.00 Price Target at Wells Fargo & Company
Wells Fargo & Company has increased its price target for Omega Healthcare Investors (NYSE:OHI) to $47.00 from $45.00, reiterating an "equal weight" rating. This new target suggests a potential upside of 4.55% for the real estate investment trust. The consensus among analysts is a "Moderate Buy" with an average target price of $48.00, reflecting varied opinions including a "Strong Buy" from one analyst and a "Buy" from five others.
23,000 Shares in Omega Healthcare Investors, Inc. $OHI Bought by Pensionfund Sabic
Pensionfund Sabic recently acquired 23,000 shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the fourth quarter, an investment valued at approximately $1.02 million. This real estate investment trust currently offers a quarterly dividend of $0.67, equating to an annualized yield of about 6.0%. Despite an elevated dividend payout ratio of 138.86%, analysts maintain a "Moderate Buy" rating for OHI, with a consensus target price of $47.82.
Pensionfund PDN Buys Shares of 46,300 Omega Healthcare Investors, Inc. $OHI
Pensionfund PDN has acquired 46,300 shares of Omega Healthcare Investors (OHI), valued at approximately $2.05 million, making it 1.4% of PDN's portfolio and their 20th largest holding. Omega Healthcare Investors pays a quarterly dividend of $0.67, representing a 6.0% yield, and institutional investors own 65.25% of the company's stock. Analysts have a consensus "Moderate Buy" rating with a price target of $47.82, and the company specializes in owning and managing healthcare-related facilities, primarily skilled nursing and assisted living.
Omega Healthcare Investors, Inc. (NYSE:OHI) Given Average Recommendation of "Moderate Buy" by Brokerages
Omega Healthcare Investors, Inc. (NYSE:OHI) has received a "Moderate Buy" consensus rating from thirteen analysts, with an average 12-month target price of $47.82. Several firms recently updated their price targets, mostly increasing them, while the company maintains a quarterly dividend of $0.67, translating to a 6.0% yield. Institutional investors hold approximately 65.25% of the stock.
OHI PE Ratio & Valuation, Is OHI Overvalued
Omega Healthcare Investors Inc (OHI) is currently considered in the "Fair zone" with a forward PE ratio of 23.20, comparable to its five-year average. Its fair price is estimated to be between $39.82 and $48.26 using a relative valuation method. Despite a P/S ratio 44.49% above the industry average, the article suggests this premium might be unsustainable given the company's robust revenue growth of 14.28%.
(OHI) Volatility Zones as Tactical Triggers
This article analyzes Omega Healthcare Investors Inc. (NYSE: OHI), highlighting a mid-channel oscillation pattern and a significant 19.2:1 risk-reward setup targeting a 5.6% gain. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis also covers multi-timeframe signal strengths, support, and resistance levels for the stock.
Omega Healthcare Investors, Inc. $OHI Shares Sold by Hudson Bay Capital Management LP
Hudson Bay Capital Management LP significantly reduced its stake in Omega Healthcare Investors (NYSE:OHI) by 69.4% in the third quarter, selling over 1.3 million shares. Despite some analysts maintaining a "Hold" consensus with an average price target of $47.82, the company recently paid a quarterly dividend of $0.67, representing a 5.7% yield, though its payout ratio is elevated at 138.86%. Omega Healthcare Investors specializes in owning and managing healthcare-related facilities, primarily skilled nursing and assisted living properties.
Net current asset value per share of Omega Healthcare Investors, Inc. – FWB:WX4
This article provides a brief financial data point regarding the net current asset value per share of Omega Healthcare Investors, Inc., traded on the Frankfurt Stock Exchange under the symbol WX4. It indicates a period value, change, and percentage change for this metric. The content itself is very minimal, appearing to be a stub or a section of a larger financial data page on TradingView.
Omega Healthcare Investors Stock (ISIN: US6821361012) Faces Pressure Amid Rising Rates and Sector Shifts
Omega Healthcare Investors (OHI) is navigating a challenging environment for healthcare REITs due to inflation, rising interest rates, and tenant challenges, despite demographic tailwinds. The company's stock, with its high dividend yield, is under scrutiny regarding occupancy trends and dividend sustainability, particularly among European investors. While AFFO meets expectations and the balance sheet is strong, refinancing risks and tenant rent coverage pressures warrant careful monitoring.
EBIT per share of Omega Healthcare Investors, Inc. – FWB:WX4
This article provides financial information for Omega Healthcare Investors, Inc. (FWB:WX4), focusing on its EBIT per share. It primarily lists the financial data provider and copyright information, along with general navigation for the TradingView platform where this data is hosted.
Omega Healthcare Investors, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance
Omega Healthcare Investors, Inc. has revised its stock evaluation, with its stock currently priced at $48.05. The company has shown strong annual performance with a 30.68% return, outperforming the S&P 500's 20.12%. Technical indicators generally suggest a positive outlook, though monthly RSI shows a short-term bearish signal.
Capitolis Liquid Global Markets LLC Makes New $12.88 Million Investment in Omega Healthcare Investors, Inc. $OHI
Capitolis Liquid Global Markets LLC has made a new $12.88 million investment in Omega Healthcare Investors, Inc. ($OHI), acquiring 305,000 shares in Q3, which represents 0.10% of the company. Omega Healthcare Investors has a consensus "Hold" rating from analysts with an average price target of $47.82, and pays a quarterly dividend of $0.67 per share, yielding 5.6% annually. A significant 65.25% of the company's stock is owned by institutional investors, with other hedge funds like JPMorgan Chase & Co. and Bank of New York Mellon Corp also increasing their stakes in the third quarter.
Cbre Investment Management Listed Real Assets LLC Invests $21.95 Million in Omega Healthcare Investors, Inc. $OHI
Cbre Investment Management Listed Real Assets LLC recently acquired a significant stake in Omega Healthcare Investors (OHI), purchasing over half a million shares worth $21.95 million. This investment comes as institutional participation in OHI is substantial, despite a high dividend payout ratio and mixed analyst ratings. While some analysts recommend buying OHI, the average rating remains "Hold" with a mean price target of $47.82.
Russell Investments Group Ltd. Raises Holdings in Omega Healthcare Investors, Inc. $OHI
Russell Investments Group Ltd. significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 32.7% in the third quarter, now holding over 2 million shares valued at $86.95 million. Despite the company's dividend yield of 5.6%, its payout ratio exceeds reported earnings at 138.9%. Analyst consensus on OHI is currently a "Hold," with an average target price near its trading price.
Price-Driven Insight from (OHI) for Rule-Based Strategy
This article provides a price-driven analysis for Omega Healthcare Investors Inc. (NYSE: OHI), highlighting weak near-term sentiment but long-term strength. It outlines three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels, along with multi-timeframe signal analysis. The analysis also notes a 17.1:1 risk-reward short setup.
Dimensional Fund Advisors LP Acquires 107,843 Shares of Omega Healthcare Investors, Inc. $OHI
Dimensional Fund Advisors LP increased its stake in Omega Healthcare Investors, Inc. (OHI) by 2.6%, purchasing an additional 107,843 shares, bringing its total holding to 4,211,183 shares valued at $177.79 million. Despite a high dividend yield of 5.6%, concerns exist about the sustainability of its 138.9% payout ratio. Analyst ratings are mixed, with a consensus "Hold" and an average target price of $47.82.
Omega Healthcare Investors, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Omega Healthcare Investors, Inc. has undergone a stock evaluation revision due to changing market conditions. The company's stock is priced at $47.07, producing a 25.35% return over the past year, outperforming the S&P 500. Technical indicators present a mixed outlook, with both bullish and bearish signals, but the company shows resilience with a 6.16% year-to-date return.
Elo Mutual Pension Insurance Co Acquires 24,902 Shares of Omega Healthcare Investors, Inc. $OHI
Elo Mutual Pension Insurance Co significantly increased its stake in Omega Healthcare Investors (OHI) by 110.6% in Q3, now owning 47,412 shares valued at approximately $2.00 million. OHI currently offers a 5.7% dividend yield, and analysts have a "Moderate Buy" consensus rating with an average target price of $47.64. The article also details other institutional investor activity and key financial metrics for Omega Healthcare Investors, a healthcare REIT.
Breaking agency to boost speciality potential: Vivage’s Jay Moskowitz
Vivage Senior Living is merging with Beecan Health to expand its specialty care offerings across 42 skilled nursing facilities, following challenges like a Medicaid cut in Colorado and staffing shortages. The CEO, Jay Moskowitz, aims to leverage increased capacity to boost occupancy, market share, and strengthen specialized programs like dementia, MS, and dialysis care. They are also addressing staffing issues with an internal float pool and enhanced recruitment to reduce reliance on external agencies.
Forecasting The Future: 7 Analyst Projections For Omega Healthcare Invts
Seven analysts have recently provided their opinions on Omega Healthcare Invts (NYSE: OHI), covering a range of sentiments from bullish to indifferent. The average 12-month price target has increased by 2.43% to $48.0, with a high estimate of $52.00 and a low of $45.00. The article also details the company's financial performance, including Q4 2025 revenue growth of 2.45%, a strong net margin of 51.64%, and efficient asset management with an ROA of 1.6% and a healthy debt-to-equity ratio of 0.82.
Omega Healthcare Investors (NYSE:OHI) Given New $48.00 Price Target at Truist Financial
Truist Financial has raised its price target for Omega Healthcare Investors (NYSE:OHI) to $48.00 from $46.00, maintaining a "hold" rating. The real estate investment trust currently holds a "Moderate Buy" consensus rating among analysts with an average price target of $47.82. Large institutional investors, including Norges Bank and Invesco Ltd., have recently increased their stakes in the company.
Omega Healthcare Investors (OHI) Valuation Check After Strong Recent Shareholder Returns
Omega Healthcare Investors (OHI) has seen a strong shareholder return recently, with a 34.8% return over the last year. Despite this, the stock, currently trading at $47.38, is considered undervalued by its most followed narrative, which pegs its fair value at $48.88. The company's disciplined balance sheet and opportunistic use of debt and equity suggest long-term growth potential, though risks like tenant credit issues or reimbursement cuts could impact its performance.
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Announces Target Price $48
Truist Financial analyst Michael Lewis has maintained a hold rating for Omega Healthcare Investors Inc (OHI.US) and set a target price of $48. According to TipRanks data, Lewis has a 63.3% success rate and a 9.0% average return over the past year. This rating is for informational purposes and not investment advice.
New Age Alpha Advisors LLC Makes New $2.55 Million Investment in Omega Healthcare Investors, Inc. $OHI
New Age Alpha Advisors LLC has made a new $2.55 million investment in Omega Healthcare Investors (NYSE:OHI), acquiring 60,438 shares. While Omega Healthcare offers a high dividend yield of 5.6%, its payout ratio of 138.9% raises concerns about dividend sustainability. The company currently holds a "Moderate Buy" consensus rating from analysts, with an average price target of $47.64.
Scotiabank Issues Positive Forecast for Omega Healthcare Investors (NYSE:OHI) Stock Price
Scotiabank has raised its price target for Omega Healthcare Investors (NYSE:OHI) from $45.00 to $48.00, maintaining a "sector perform" rating. This new target suggests a marginal downside of 0.46% from the current trading price. The stock has a "Moderate Buy" average rating from analysts, with various firms providing mixed ratings from "Strong Buy" to "Hold", and institutional investors hold a significant portion of the shares.
Cash per share of Omega Healthcare Investors, Inc. – MUN:WX4
This article provides financial information for Omega Healthcare Investors, Inc. (MUN:WX4) on TradingView, specifically focusing on its cash per share. It outlines various data sources used, such as ICE Data Services and FactSet, and indicates the stock is listed on the Munich Stock Exchange. The content is primarily a data page, not an analytical article.
EBITDA per share of Omega Healthcare Investors, Inc. – MUN:WX4
This article provides the EBITDA per share information for Omega Healthcare Investors, Inc. under the ticker symbol WX4 on the Munich Stock Exchange. It is a brief financial data point from TradingView, indicating no current trades as the market is closed. The content primarily focuses on presenting this specific financial metric.
Intech Investment Management LLC Has $12.97 Million Stake in Omega Healthcare Investors, Inc. $OHI
Intech Investment Management LLC significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 63.8% in Q3, now holding 307,222 shares valued at approximately $12.97 million. The company pays a quarterly dividend of $0.67, yielding about 5.6%, but its high payout ratio of 138.86% raises potential sustainability concerns. Wall Street analysts have a "Moderate Buy" consensus rating for OHI with an average price target of $47.36.
OHI SEC Filings - Omega Healthcare 10-K, 10-Q, 8-K Forms
This page provides access to Omega Healthcare Investors, Inc. (OHI) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It details how Omega, a real estate investment trust focused on long-term healthcare properties, finances and manages its portfolio. The platform also offers AI-powered summaries of these documents to help investors understand key changes and updates.
Omega Healthcare Investors stock reaches all-time high at 47.94 USD By Investing.com
Omega Healthcare Investors (OHI) stock has hit an all-time high of $47.94, marking a 38.55% total return over the last 12 months. Despite this surge, InvestingPro analysis suggests the stock remains undervalued with a P/E ratio of 24.37 and offers a 5.64% dividend yield, maintaining payments for 24 consecutive years. Recent financial results show the company exceeded Q4 2025 earnings and revenue expectations, and Cantor Fitzgerald raised its price target to $52.00, citing strong external growth forecast for 2025 and over $200 million in investments completed for early 2026.
(OHI) Price Dynamics and Execution-Aware Positioning
This article analyzes Omega Healthcare Investors Inc. (NYSE: OHI) with a near-term neutral sentiment amidst mid and long-term strength. It highlights a critical resistance test, provides three AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging), and detailed multi-timeframe signal analysis with support and resistance levels. The report also notes an exceptional 16.3:1 risk-reward short setup opportunity.
Omega Healthcare Investors (NYSE:OHI) Stock Price
This article provides an overview of Omega Healthcare Investors (NYSE:OHI), highlighting its stock price performance, future dividend coverage, and sector resilience. It notes that demographic trends and legislative changes boost demand for Omega's skilled nursing and senior care operations, supporting occupancy and earnings predictability. The company's prudent balance sheet management and strategic acquisitions contribute to portfolio diversification and long-term revenue growth.
Did Renewed Demand For High-Yield REITs Just Reshape Omega Healthcare Investors' (OHI) Income Narrative?
Renewed interest in high-yield dividend REITs has brought Omega Healthcare Investors (OHI) into focus due to its strong income profile and cash flow resilience. The article highlights OHI's consistent dividend payout of US$0.67 per share, supported by its healthcare-focused real estate portfolio, and its institutional ownership, positioning it as a stable option for income-seeking investors. Despite a wide range of fair value estimates, the company's long-term viability hinges on its ability to manage tenant credit quality, regulatory, and reimbursement risks.
Greenland Capital Management LP Purchases 96,230 Shares of Omega Healthcare Investors, Inc. $OHI
Greenland Capital Management LP significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 269% in the third quarter, acquiring 96,230 additional shares, bringing its total to 132,000 shares valued at approximately $5.57 million. The company recently paid a $0.67 quarterly dividend, resulting in a 5.7% yield, but its payout ratio of 138.86% raises sustainability concerns. Analysts maintain a "Moderate Buy" rating for OHI with a consensus target price of $47.36.
High Yield Revival: 3 Cash-Rich Dividend Payers on Sale
Amid market volatility and a rotation out of high-growth tech stocks, investors are now prioritizing dividend-paying stocks with steady cash flows for reliable income. This article highlights three cash-rich dividend payers: Omega Healthcare Inc. (OHI), Perrigo Company (PRGO), and Omnicom Group Inc. (OMC), which offer attractive yields above the Invesco S&P 500 High Dividend Low Volatility ETF (SPHD). These companies provide stability and income potential for investors seeking value in a changing market landscape, with detailed reasons for their appeal.
